{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T21:24:48Z","timestamp":1784841888211,"version":"3.55.0"},"reference-count":43,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1097\/mnh.0b013e32836214d4","type":"journal-article","created":{"date-parts":[[2013,6,4]],"date-time":"2013-06-04T12:59:48Z","timestamp":1370350788000},"page":"413-420","source":"Crossref","is-referenced-by-count":26,"title":["Use of phosphate binders in chronic kidney disease"],"prefix":"10.1097","volume":"22","author":[{"given":"Markus","family":"Ketteler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick H.","family":"Biggar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-9-20210205","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/1471-2458-8-117","article-title":"Prevalence of chronic kidney disease in population-based studies: systematic review.","volume":"8","author":"Zhang","year":"2008","journal-title":"BMC Public Health"},{"key":"R2-9-20210205","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1038\/ki.2011.368","article-title":"The contribution of chronic kidney disease to the global burden of major noncommunicable diseases.","volume":"80","author":"Couser","year":"2011","journal-title":"Kidney Int"},{"key":"R3-9-20210205","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1161\/CIRCRESAHA.110.234914","article-title":"Arterial calcification in chronic kidney disease: key roles for calcium and phosphate.","volume":"109","author":"Shanahan","year":"2011","journal-title":"Circ Res"},{"key":"R4-9-20210205","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1681\/ASN.2008101106","article-title":"Dietary phosphorus acutely impairs endothelial function.","volume":"20","author":"Shuto","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"R5-9-20210205","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1097\/01.ASN.0000133041.27682.A2","article-title":"Mineral metabolism, mortality, and morbidity in maintenance hemodialysis.","volume":"15","author":"Block","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"R6-9-20210205","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1093\/ndt\/gfq219","article-title":"Serum iPTH, calcium and phosphate, and the risk of mortality in a European haemodialysis population.","volume":"26","author":"Floege","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"R7-9-20210205","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1056\/NEJMra0912522","article-title":"Oral phosphate binders in patients with kidney failure.","volume":"362","author":"Tonelli","year":"2010","journal-title":"N Engl J Med"},{"key":"R8-9-20210205","doi-asserted-by":"crossref","first-page":"3719","DOI":"10.1002\/jps.22614","article-title":"Sodium-dependent phosphate cotransporters: lessons from gene knockout and mutation studies.","volume":"100","author":"Miyamoto","year":"2011","journal-title":"J Pharm Sci"},{"key":"R9-9-20210205","first-page":"S1","article-title":"Kidney Disease: Improving Global Outcomes CKDMBDWG. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD).","volume":"76","author":"Moe","year":"2009","journal-title":"Kidney Int"},{"key":"R10-9-20210205","first-page":"49","article-title":"Phosphate additives in food: a health risk.","volume":"109","author":"Ritz","year":"2012","journal-title":"Dtsch Arztebl Int"},{"key":"R11-9-20210205","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1001\/jama.2009.96","article-title":"Effect of food additives on hyperphosphatemia among patients with end-stage renal disease: a randomized controlled trial.","volume":"301","author":"Sullivan","year":"2009","journal-title":"JAMA"},{"key":"R12-9-20210205","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1053\/j.jrn.2011.12.010","article-title":"Novel differential measurement of natural and added phosphorus in cooked ham with or without preservatives.","volume":"22","author":"Cupisti","year":"2012","journal-title":"J Ren Nutr"},{"key":"R13-9-20210205","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1681\/ASN.2011070688","article-title":"Effects of frequent hemodialysis on measures of CKD mineral and bone disorder.","volume":"23","author":"Daugirdas","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"R14-9-20210205","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1053\/j.ajkd.2011.12.025","article-title":"Phosphate binder use and mortality among hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS): evaluation of possible confounding by nutritional status.","volume":"60","author":"Lopes","year":"2012","journal-title":"Am J Kidney Dis"},{"key":"R15-9-20210205","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1681\/ASN.2008060609","article-title":"Phosphorus binders and survival on hemodialysis.","volume":"20","author":"Isakova","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"R16-9-20210205","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1111\/j.1523-1755.2004.00590.x","article-title":"Treatment of hyperphosphatemia in hemodialysis patients: the Calcium Acetate Renagel Evaluation (CARE Study).","volume":"65","author":"Qunibi","year":"2004","journal-title":"Kidney Int"},{"key":"R17-9-20210205","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/j.1542-4758.2011.00575.x","article-title":"Calcium carbonate, but not sevelamer, is associated with better outcomes in hemodialysis patients: results from the French ARNOS study.","volume":"15","author":"Jean","year":"2011","journal-title":"Hemodial Int"},{"key":"R18-9-20210205","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1056\/NEJM200005183422003","article-title":"Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis.","volume":"342","author":"Goodman","year":"2000","journal-title":"N Engl J Med"},{"key":"R19-9-20210205","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.2215\/CJN.05161107","article-title":"Efficacy and tolerability of sevelamer carbonate in hyperphosphatemic patients who have chronic kidney disease and are not on dialysis.","volume":"3","author":"Ketteler","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"R20-9-20210205","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1046\/j.1523-1755.2002.00434.x","article-title":"Treat to Goal Working GroupSevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients.","volume":"62","author":"Chertow","year":"2002","journal-title":"Kidney Int"},{"key":"R21-9-20210205","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1111\/j.1523-1755.2005.00600.x","article-title":"Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis.","volume":"68","author":"Block","year":"2005","journal-title":"Kidney Int"},{"key":"R22-9-20210205","doi-asserted-by":"crossref","first-page":"c259","DOI":"10.1159\/000313484","article-title":"Meta-analysis comparing sevelamer and calcium-based phosphate binders on cardiovascular calcification in hemodialysis patients.","volume":"115","author":"Zhang","year":"2010","journal-title":"Nephron Clin Pract"},{"key":"R23-9-20210205","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1038\/sj.ki.5002466","article-title":"Effects of sevelamer and calcium-based phosphate binders on mortality in hemodialysis patients.","volume":"72","author":"Suki","year":"2007","journal-title":"Kidney Int"},{"key":"R24-9-20210205","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/sj.ki.5002059","article-title":"Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients.","volume":"71","author":"Block","year":"2007","journal-title":"Kidney Int"},{"key":"R25-9-20210205","doi-asserted-by":"crossref","first-page":"487","DOI":"10.2215\/CJN.03820411","article-title":"Mortality in kidney disease patients treated with phosphate binders: a randomized study.","volume":"7","author":"Di Iorio","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"R26-9-20210205","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1093\/ndt\/gfq053","article-title":"Serological cardiovascular and mortality risk predictors in dialysis patients receiving sevelamer: a prospective study.","volume":"25","author":"Brandenburg","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"R27-9-20210205","first-page":"286","article-title":"Early control of PTH and FGF23 in normophosphatemic CKD patients: a new target in CKD-MBD therapy Clin J Am Soc N","volume":"5","author":"Oliveira","year":"2010","journal-title":"ephrol"},{"key":"R28-9-20210205","doi-asserted-by":"crossref","first-page":"252","DOI":"10.5414\/CNP72252","article-title":"Lanthanum carbonate vs. sevelamer hydrochloride for the reduction of serum phosphorus in hemodialysis patients: a crossover study.","volume":"72","author":"Sprague","year":"2009","journal-title":"Clinical Nephrol"},{"key":"R29-9-20210205","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1093\/ndt\/gfr144","article-title":"Lanthanum carbonate reduces FGF23 in chronic kidney disease Stage 3 patients.","volume":"26","author":"Gonzalez-Parra","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"R30-9-20210205","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1046\/j.1523-1755.63.s85.18.x","article-title":"A multicenter study on the effects of lanthanum carbonate (Fosrenol) and calcium carbonate on renal bone disease in dialysis patients.","volume":"85","author":"DHaese","year":"2003","journal-title":"Kidney Int Suppl"},{"key":"R31-9-20210205","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1111\/j.1523-1755.2005.00171.x","article-title":"Chronic renal failure is associated with increased tissue deposition of lanthanum after 28-day oral administration.","volume":"67","author":"Lacour","year":"2005","journal-title":"Kidney Int"},{"key":"R32-9-20210205","first-page":"286","article-title":"Lanthanum Carbonate Study GroupLanthanum carbonate treatment, for up to 6 years, is not associated with adverse effects on the liver in patients with chronic kidney disease Stage 5 receiving hemodialysis.","volume":"71","author":"Hutchison","year":"2009","journal-title":"Clin Nephrol"},{"key":"R33-9-20210205","doi-asserted-by":"crossref","first-page":"3707","DOI":"10.1093\/ndt\/gfq292","article-title":"Evaluation of calcium acetatemagnesium carbonate as a phosphate binder compared with sevelamer hydrochloride in haemodialysis patients: a controlled randomized study (CALMAG study) assessing efficacy and tolerability.","volume":"25","author":"de Francisco","year":"2010","journal-title":"Nephrol Dial Transplant"},{"issue":"Suppl 1","key":"R34-9-20210205","doi-asserted-by":"crossref","first-page":"i52","DOI":"10.1093\/ndtplus\/sfr167","article-title":"Magnesium and outcomes in patients with chronic kidney disease: focus on vascular calcification, atherosclerosis and survival.","volume":"5","author":"Massy","year":"2012","journal-title":"Clin Kidney J"},{"key":"R35-9-20210205","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1093\/ndt\/gfp445","article-title":"Effect of MCI-196 on serum phosphate and cholesterol levels in haemodialysis patients with hyperphosphataemia: a double-blind, randomized, placebo-controlled study.","volume":"25","author":"Locatelli","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"R36-9-20210205","doi-asserted-by":"crossref","first-page":"280","DOI":"10.2215\/CJN.08230811","article-title":"Randomized clinical trial of the iron-based phosphate binder PA21 in hemodialysis patients.","volume":"8","author":"Wuthrich","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"R37-9-20210205","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1053\/j.ajkd.2012.11.041","article-title":"Collaborative Study GroupDose-response and efficacy of ferric citrate to treat hyperphosphatemia in hemodialysis patients: a short-term randomized trial.","volume":"61","author":"Dwyer","year":"2013","journal-title":"Am J Kidney Dis"},{"key":"R38-9-20210205","doi-asserted-by":"crossref","first-page":"582","DOI":"10.2215\/CJN.07341009","article-title":"Hypophosphatemic effect of niacin in patients without renal failure: a randomized trial.","volume":"5","author":"Maccubbin","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"R39-9-20210205","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.2215\/CJN.04211007","article-title":"A randomized, double-blind, placebo-controlled trial of niacinamide for reduction of phosphorus in hemodialysis patients.","volume":"3","author":"Cheng","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"R40-9-20210205","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1681\/ASN.2012030223","article-title":"Effects of phosphate binders in moderate CKD.","volume":"23","author":"Block","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"R41-9-20210205","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1038\/ki.2012.403","article-title":"Oral calcium carbonate affects calcium but not phosphorus balance in stage 3-4 chronic kidney disease.","volume":"83","author":"Hill","year":"2013","journal-title":"Kidney Int"},{"key":"R42-9-20210205","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1471-2369-9-2","article-title":"A systematic review of the prevalence and determinants of nonadherence to phosphate binding medication in patients with end-stage renal disease.","volume":"9","author":"Karamanidou","year":"2008","journal-title":"BMC Nephrol"},{"key":"R43-9-20210205","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.2215\/CJN.00290109","article-title":"Pill burden, adherence, hyperphosphatemia, and quality of life in maintenance dialysis patients.","volume":"4","author":"Chiu","year":"2009","journal-title":"Clin J Am Soc Nephrol"}],"container-title":["Current Opinion in Nephrology & Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MNH.0b013e32836214d4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T03:29:49Z","timestamp":1620962989000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00041552-201307000-00009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":43,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/mnh.0b013e32836214d4","relation":{},"ISSN":["1062-4821"],"issn-type":[{"value":"1062-4821","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7]]}}}